A Focus on Toxicity Management - Part 1

Monday, April 24, 2023 | 12-4 P.M. CDT
Hybrid | VIRTUAL AND Chicago, IL

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of toxicity management. Part 1 will cover etiology and management strategies for pneumonitis, endocrinopathies, dermatologic, cardiac, and rheumatologic toxicities. Free for healthcare professionals, students, patients and patient advocates.

Register Now

Located in the Chicago area? Be sure to join us in-person so you can take advantage of the opportunity to network with the faculty in your area and enjoy a lunch interacting with your peers and experts in the field.

Program Organizers

Christine Bestvina, MD
University of Chicago

Trevor Christ, PharmD, BCOP
Rush University Medical Center

Pankti Reid, MD, MPH University of Chicago Medical Center

Program Agenda

11-12 p.m.


In-Person Attendees: Complimentary Networking Lunch

11:55 a.m.-12 p.m.


Welcome and Relevant SITC Resources

12-12:20 p.m.


Intro to Immunotherapy and Toxicities, Updates on Recent Approvals

Trevor Christ, PharmD, BCOP – Rush University Medical Center

12:20- 12:40 p.m.


Biomarker Update

Alan Tan, MD – Rush University Medical Center

12:40-1 p.m.


Cardiac Toxicities

Nausheen Akhter, MD - Northwestern Medicine

1-1:20 p.m.


Pulmonary and Rheumatic Toxicities

Pankti Reid, MD, MPH – University of Chicago

1:20-1:40 p.m.


Dermatologic Toxicities

Angad Chadha, MD - University of Chicago Medical Center

1:40-2 p.m.



Katie O'Sullivan, MD - University of Chicago Medical Center

2-2:30 p.m.



2:30-3:10 p.m.


Cancer Immunotherapy In Practice

Irene E Haapoja, CNS – Rush University Medical Center

Christine Bestvina, MD – University of Chicago

3:10-4 p.m.


Faculty Panel

4 p.m.

Closing Remarks

Program Details

Venue information

The Westin Michigan Ave

909 North Michigan Avenue | Chicago, IL 60611

Rise and rejuvenate your body and mind at our Chicago Gold Coast hotel on Michigan Avenue and Body Rituals Boutique Spa. Located within walking distance of Oak Street Beach, luxury fashion at 900 North Michigan Shops, the breathtaking 360 Chicago Observation Deck, and all of Chicago's most famous attractions, The Westin Michigan Avenue Chicago hotel offers pet-friendly hotel rooms and spacious suites featuring sweeping lake views, a renowned Heavenly® Bed and relaxing bath amenities.

Program Learning Objectives

  • Identify appropriate clinical management of common immune-related adverse events resulting from cancer immunotherapy treatments, including immune checkpoint inhibitors and cell therapies.

  • Outline best practices for multidisciplinary management of patients receiving cancer immunotherapy treatment.

  • Describe management approaches for difficult or refractory immune-related adverse events.

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Case Study Submission Information

As part of the program, registrants are encouraged to submit case studies for expert review during the case study panel concluding the program. If you are interested in taking advantage of this opportunity, please review and sign the linked case study guidelines, and return your case study and signed guidelines to education@sitcancer.org.

COVID-19 Measures >

At SITC programs, our goal is to have a safe and meaningful in-person experience. SITC will refer to the CDC COVID-19 Community Levels to guide health precautions for in-person meetings. In addition, SITC strongly recommends that in-person meeting attendees take the following precautions: 
•    Stay up to date with COVID-19 vaccinations.
•    Take a rapid COVID test prior to attending a meeting and do not attend in person if you test positive.
•    Do not attend the meeting if you have symptoms that could be consistent with a “cold” or any other respiratory infection and leave the meeting if you develop such symptoms.
•    Wear a mask in crowded indoor settings. 
•    Follow all health and safety protocols as required by SITC and local and state health departments.
•    Review current CDC and applicable local guidance for protecting yourself from COVID-19.
Attendees will have access to the meeting content online if they are unable to attend in person due to illness or a positive COVID test. For hybrid programs, attendees can change from in-person to online-only registration by contacting events@sitcancer.org
Registered attendees will be notified in advance of any changes to precautions, recommendations or requirements for a SITC meeting.

The 2023 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Bristol Myers Squibb, Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD) and Novartis Pharmaceuticals Corporation. (as of 3/8/2023)

Accreditation Information

Joint Accreditation Statement

thumbnail image In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Society for Immunotherapy of Cancer (SITC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)

ABIM_Logo.jpgSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Continuing Medical Education

PACE designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

PACE designates this continuing education activity for 3.5 contact hour(s) (0.35 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Nursing Education

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Disclosures and ADA Info

Disclosure of Conflicts of Interest

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact SITC Staff prior to the live event at (414) 271-2456 or via email education@sitcancer.org.

Avoid Fraudulent ACI Websites

Recently, the SITC office received communication about a fraudulent registration website for one of our ACI programs. To help ensure others don’t mistakenly register on an unauthorized, third-party website, we're proactively informing you to ensure you’re able to safely register for the event through the official SITC website, and so that you can confirm the communication you receive is truly from SITC.

All official forthcoming ACI registration information will come from an email address ending in @sitcancer.org. If you have any questions, please contact the SITC office at events@sitcancer.org or 414-271-2456.